Vernon R. J. Clarke

Vernon R. J. Clarke

Auto-generated profile, based on publicly available information

Vernon R. J. Clarke

Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Nature
Verified
Journal Article
Closed access
PDF file
VCVernon R. J. Clarke
Vernon R. J. Clarke
BBBarbara A. Ballyk
Barbara A. Ballyk
KHKen H. Hoo
Ken H. Hoo
AMAllan Mandelzys
Allan Mandelzys
APAndrew Pellizzari
Andrew Pellizzari
DBDavid Bleakman
David Bleakman

18 November 1999 in Nature
Verified
Journal Article
Closed access
PDF file
ZBZuner A. Bortolotto
Zuner A. Bortolotto
VCVernon R. J. Clarke
Vernon R. J. Clarke
CDCaroline M. Delany
Caroline M. Delany
MPMichael C. Parry
Michael C. Parry
ISIlse Smolders
Ilse Smolders
GCGraham L. Collingridge
Graham L. Collingridge

1 January 1999 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
RCRamesh Chittajallu
Ramesh Chittajallu
SBSteven P Braithwaite
Steven P Braithwaite
VCVernon R.J Clarke
Vernon R.J Clarke
JHJeremy M Henley
Jeremy M Henley

15 November 2001 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GSGilles Sansig
Gilles Sansig
TBTrevor Bushell
Trevor Bushell
VCVernon R. J. Clarke
Vernon R. J. Clarke
ARAndrei Rozov
Andrei Rozov
NBNail Burnashev
Nail Burnashev
HPHerman van der Putten
Herman van der Putten
To study the role of mGlu7 receptors (mGluR7), we used homologous recombination to generate mice lacking this metabotropic receptor subtype (mGluR7−/−). After the serendipitous discovery of a sensory stimulus-evoked epileptic phenotype, we tested two convulsant drugs, pentylenetetrazole (PTZ) and bicuculline. In animals aged 12 weeks and older, subthreshold doses of these drugs induced seizures in mGluR7−/−, but not in mGluR7+/−, mice. PTZ-induced seizures were inhibited by three standard anticonvulsant drugs, but not by the group III selective mGluR agonist (R,S)-4-phosphonophenylglycine (PPG). Consistent with the lack of signs of epileptic activity in the absence of specific stimuli, mGluR7−/−mice showed no major changes in synaptic properties in two slice preparations. However, slightly increased excitability was evident in hippocampal slices. In addition, there was slower recovery from frequency facilitation in cortical slices, suggesting a role for mGluR7 as a frequency-dependent regulator in presynaptic terminals. Our findings suggest that mGluR7 receptors have a unique role in regulating neuronal excitability and that these receptors may be a novel target for the development of anticonvulsant drugs.

24 June 2002 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ISIlse Smolders
Ilse Smolders
ZBZuner A. Bortolotto
Zuner A. Bortolotto
VCVernon R. J. Clarke
Vernon R. J. Clarke
RWRuth Warre
Ruth Warre
GKGhous M. Khan
Ghous M. Khan
YMYvette Michotte
Yvette Michotte

1 October 1998 in Neuropharmacology
Verified
Journal Article
Closed access
MVMichel Vignes
Michel Vignes
VCV.R.J Clarke
V.R.J Clarke
MPM.J Parry
M.J Parry
DBD Bleakman
D Bleakman
DLD Lodge
D Lodge
GCG.L Collingridge
G.L Collingridge